Tacrolimus for the management of psoriasis: clinical utility and place in therapy
Nina Malecic,1,2 Helen Young2 1Manchester Medical School, 2The Dermatology Research Centre, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK Abstract: Psoriasis affects 1%–3% of the population in the United Kingdom and can convey significant detriment to...
Guardado en:
Autores principales: | Malecic N, Young H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/be6680819bf14dcdbe55d54dd2411f57 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Management of scalp psoriasis: current perspectives
por: Blakely K, et al.
Publicado: (2016) -
Perspective trends of topical therapy of patients with psoriasis
por: Alexander S. Zhukov, et al.
Publicado: (2021) -
Phosphodiesterase-4 Inhibition in Psoriasis
por: Milakovic M, et al.
Publicado: (2021) -
An Open-Label Prospective Study to Compare the Efficacy and Safety of Topical Fluticasone Versus Tacrolimus in the Proactive Treatment of Atopic Dermatitis
por: Vinodhini R. Mudaliyar, et al.
Publicado: (2020) -
Psoriasis in children
por: Pinson R, et al.
Publicado: (2016)